Metformin stimulates FGF21 expression in primary hepatocytes

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Nygaard, Eva B ^a,b   Vienberg, Sara G ^b   Orskov, Cathrine ^c   Hansen, Harald S ^a   Andersen, Birgitte ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FIBROBLAST GROWTH FACTOR 21; METFORMIN; (6 (4 (2 PIPERIDIN 1 YLETHOXY)PHENYL)) 3 PYRIDIN 4 YLPYRAZOLO(1,5 A)PYRIMIDINE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; ANTIDIABETIC AGENT; FIBROBLAST GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; HUMAN; HUMAN CELL; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GLYCOGEN LIVER LEVEL; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SUBUNIT; SPRAGUE DAWLEY RAT; UPREGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTORS; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; LIVER GLYCOGEN; MALE; METFORMIN; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 84869002483     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/465282     Document Type: Article

References (31)

1. Badman M. K., Pissios P., Kennedy A. R., Koukos G., Flier J. S., Maratos-Flier E., Hepatic fibroblast growth factor 21 is regulated by PPAR α and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 2007 5 6 426 437 2-s2.0-34249711964 10.1016/j.cmet.2007.05.002 (Pubitemid 46825495)
2. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., Elmquist J. K., Gerard R. D., Burgess S. C., Hammer R. E., Mangelsdorf D. J., Kliewer S. A., Endocrine regulation of the fasting response by PPAR α -mediated induction of fibroblast growth factor 21. Cell Metabolism 2007 5 6 415 425 2-s2.0-34249686631 10.1016/j.cmet.2007.05. 003 (Pubitemid 46825496)
3. Kharitonenkov A., Shiyanova T. L., Koester A., Ford A. M., Micanovic R., Galbreath E. J., Sandusky G. E., Hammond L. J., Moyers J. S., Owens R. A., Gromada J., Brozinick J. T., Hawkins E. D., Wroblewski V. J., Li D. S., Mehrbod F., Jaskunas S. R., Shanafelt A. B., FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 2005 115 6 1627 1635 2-s2.0-20444435873 10.1172/JCI23606 (Pubitemid 40814671)
4. Tacer K. F., Bookout A. L., Ding X., Kurosu H., John G. B., Wang L., Goetz R., Mohammadi M., Kuro-o M., Mangelsdorf D. J., Kliewer S. A., Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Molecular Endocrinology 2010 24 10 2050 2064 2-s2.0-77957376253 10.1210/me.2010-0142
5. Iizuka K., Takeda J., Horikawa Y., Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. The FEBS Letters 2009 583 17 2882 2886 2-s2.0-69249238074 10.1016/j.febslet.2009.07.053
6. Iizuka K., Takeda J., Horikawa Y., Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. The FEBS Letters 2009 583 17 2882 2886 2-s2.0-69249238074 10.1016/j.febslet.2009.07.053
7. Chen W. W., Li L., Yang G. Y., Li K., Qi X. Y., Zhu W., Tang Y., Liu H., Boden G., Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 2008 116 1 65 68 2-s2.0-39449127028 10.1055/s-2007-985148 (Pubitemid 351270911)
8. Dushay J., Chui P. C., Gopalakrishnan G. S., Varela-Rey M., Crawley M., Fisher F. M., Badman M. K., Martinez-Chantar M. L., Maratos-Flier E., Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010 139 2 456 463 2-s2.0-77955474305 10.1053/j.gastro.2010.04. 054
9. Zhang X., Yeung D. C. Y., Karpisek M., Stejskal D., Zhou Z. G., Liu F., Wong R. L. C., Chow W. S., Tso A. W. K., Lam K. S. L., Xu A., Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 57 5 1246 1253 2-s2.0-48349146527 10.2337/db07-1476
10. Gälman C., Lundåsen T., Kharitonenkov A., Bina H. A., Eriksson M., Hafström I., Dahlin M., Åmark P., Angelin B., Rudling M., The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPAR α activation in man. Cell Metabolism 2008 8 2 169 174 2-s2.0-48349127924 10.1016/j.cmet.2008.06.014
11. Lundåsen T., Hunt M. C., Nilsson L. M., Sanyal S., Angelin B., Alexson S. E. H., Rudling M., PPAR α is a key regulator of hepatic FGF21. Biochemical and Biophysical Research Communications 2007 360 2 437 440 2-s2.0-34447265235 10.1016/j.bbrc.2007.06.068 (Pubitemid 47039157)
12. Coskun T., Bina H. A., Schneider M. A., Dunbar J. D., Hu C. C., Chen Y., Moller D. E., Kharitonenkov A., Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008 149 12 6018 6027 2-s2.0-57349098220 10.1210/en.2008-0816
13. Kharitonenkov A., Shiyanova T. L., Koester A., Ford A. M., Micanovic R., Galbreath E. J., Sandusky G. E., Hammond L. J., Moyers J. S., Owens R. A., Gromada J., Brozinick J. T., Hawkins E. D., Wroblewski V. J., Li D. S., Mehrbod F., Jaskunas S. R., Shanafelt A. B., FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 2005 115 6 1627 1635 2-s2.0-20444435873 10.1172/JCI23606 (Pubitemid 40814671)
14. Kharitonenkov A., Wroblewski V. J., Koester A., Chen Y. F., Clutinger C. K., Tigno X. T., Hansen B. C., Shanafelt A. B., Etgen G. J., The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007 148 2 774 781 2-s2.0-33846418834 10.1210/en.2006-1168 (Pubitemid 46143178)
15. Kirpichnikov D., McFarlane S. I., Sowers J. R., Metformin: an update. Annals of Internal Medicine 2002 137 1 25 33 2-s2.0-0037008045 (Pubitemid 34705373)
16. Maida A., Lamont B. J., Cao X., Drucker D. J., Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor- α in mice. Diabetologia 2011 54 2 339 349 2-s2.0-78951476273 10.1007/s00125-010-1937-z
17. Owen M. R., Doran E., Halestrap A. P., Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 2000 348 3 607 614 2-s2.0-0034659785 10.1042/0264-6021:3480607 (Pubitemid 30410251)
18. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 2001 108 8 1167 1174 2-s2.0-0034773404 10.1172/JCI200113505 (Pubitemid 32995375)
19. Andersen B., Rassov A., Westergaard N., Lundgren K., Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-D-arabinitol. Biochemical Journal 1999 342 3 545 550 2-s2.0-0033567989 10.1042/0264-6021: 3420545 (Pubitemid 29452639)
20. Rozen S., Skaletsky H., Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 2000 132 365 386 2-s2.0-0033990048
21. Gómez-Lechón M. J., Ponsoda X., Castell J. V., A microassay for measuring glycogen in 96-well-cultured cells. Analytical Biochemistry 1996 236 2 296 301 2-s2.0-0343431440 10.1006/abio.1996.0170 (Pubitemid 26136109)
22. Hawley S. A., Davison M., Woods A., Davies S. P., Beri R. K., Carling D., Hardie D. G., Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. Journal of Biological Chemistry 1996 271 44 27879 27887 2-s2.0-0029910018 10.1074/jbc.271.44.27879 (Pubitemid 26367365)
23. Otto M., Breinholt J., Westergaard N., Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes, Obesity and Metabolism 2003 5 3 189 194 2-s2.0-0344643429 10.1046/j.1463-1326.2003.00263.x (Pubitemid 36519352)
24. Chau M. D. L., Gao J., Yang Q., Wu Z., Gromada J., Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1 α pathway. Proceedings of the National Academy of Sciences of the United States of America 2010 107 28 12553 12558 2-s2.0-77955434383 10.1073/pnas.1006962107
25. Berglund E. D., Kang L., Lee-Young R. S., Hasenour C. M., Lustig D. G., Lynes S. E., Donahue E. P., Swift L. L., Charron M. J., Wasserman D. H., Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPAR α and FGF21 transcripts in vivo. American Journal of Physiology 2010 299 4 E607 E614 2-s2.0-77957556136 10.1152/ajpendo.00263.2010
26. Tyynismaa H., Carroll C. J., Raimundo N., Ahola-erkkilä S., Wenz T., Ruhanen H., Guse K., Hemminki A., Peltola-Mjosund K. E., Tulkki V., Orešič M., Moraes C. T., Pietiläinen K., Hovatta I., Suomalainen A., Mitochondrial myopathy induces a starvation-like response. Human Molecular Genetics 2010 19 20 3948 3958 2-s2.0-77957743736 10.1093/hmg/ddq310 ddq310
27. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., Elmquist J. K., Gerard R. D., Burgess S. C., Hammer R. E., Mangelsdorf D. J., Kliewer S. A., Endocrine regulation of the fasting response by PPAR α -mediated induction of fibroblast growth factor 21. Cell Metabolism 2007 5 6 415 425 2-s2.0-34249686631 10.1016/j.cmet.2007.05. 003 (Pubitemid 46825496)
28. Potthoff M. J., Inagaki T., Satapati S., Ding X., He T., Goetz R., Mohammadi M., Finck B. N., Mangelsdorf D. J., Kliewer S. A., Burgess S. C., FGF21 induces PGC-1 α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proceedings of the National Academy of Sciences of the United States of America 2009 106 26 10853 10858 2-s2.0-67649823642 10.1073/pnas.0904187106
29. Dutchak P. A., Katafuchi T., Bookout A. L., Choi J. H., Yu R. T., Mangelsdorf D. J., Kliewer S. A., Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 2012 148 556 567 10.1016/j.cell.2011.11.062
30. Li H., Gao Z., Zhang J., Ye X., Xu A., Ye J., Jia W., Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. Diabetes 2012 61 797 806
31. Fisher F. M., Chui P. C., Antonellis P. J., Bina H. A., Kharitonenkov A., Flier J. S., Maratos-Flier E., Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010 59 11 2781 2789 2-s2.0-78049297991 10.2337/db10-0193